Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
2.
combating racial discrimination in next-generation breast cancer screening.
3.
Herpes virus-based vaccine shows promise in targeting tumors without side effects
4.
Use of social media during pregnancy may increase depression.
5.
Infection Burden High With Myeloma T-Cell Therapies
1.
Patient Management Following Organ-Preserving Cancer Interventions
2.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
3.
Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier
4.
Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment
5.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Current Scenario of Cancer- Q&A Session to Close the Gap
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge